JPS61129129A - 抗腫瘍剤 - Google Patents

抗腫瘍剤

Info

Publication number
JPS61129129A
JPS61129129A JP25128484A JP25128484A JPS61129129A JP S61129129 A JPS61129129 A JP S61129129A JP 25128484 A JP25128484 A JP 25128484A JP 25128484 A JP25128484 A JP 25128484A JP S61129129 A JPS61129129 A JP S61129129A
Authority
JP
Japan
Prior art keywords
methyl
antitumor agent
tumor
formula
agent containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP25128484A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0430924B2 (enExample
Inventor
Masanori Ubusawa
生沢　政則
Tamotsu Kano
狩野　保
Kenichi Matsunaga
謙一 松永
Takami Fujii
藤井　孝美
Shigeaki Muto
武藤　成明
Takao Furusho
古荘　孝雄
Chikao Yoshikumi
吉汲　親雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Priority to JP25128484A priority Critical patent/JPS61129129A/ja
Publication of JPS61129129A publication Critical patent/JPS61129129A/ja
Publication of JPH0430924B2 publication Critical patent/JPH0430924B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP25128484A 1984-11-28 1984-11-28 抗腫瘍剤 Granted JPS61129129A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP25128484A JPS61129129A (ja) 1984-11-28 1984-11-28 抗腫瘍剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25128484A JPS61129129A (ja) 1984-11-28 1984-11-28 抗腫瘍剤

Publications (2)

Publication Number Publication Date
JPS61129129A true JPS61129129A (ja) 1986-06-17
JPH0430924B2 JPH0430924B2 (enExample) 1992-05-25

Family

ID=17220510

Family Applications (1)

Application Number Title Priority Date Filing Date
JP25128484A Granted JPS61129129A (ja) 1984-11-28 1984-11-28 抗腫瘍剤

Country Status (1)

Country Link
JP (1) JPS61129129A (enExample)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0784055A4 (en) * 1994-09-26 1998-01-07 Daiichi Seiyaku Co PYRIMIDINYLPYRAZOLE DERIVATIVE
EP1022270A4 (en) * 1997-01-27 2002-01-30 Daiichi Seiyaku Co PIRAZOLE DERIVATIVES
US6552018B1 (en) 1997-01-27 2003-04-22 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives
FR2850379A1 (fr) * 2003-01-28 2004-07-30 Aventis Pharma Sa Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
WO2004078732A1 (fr) * 2003-01-28 2004-09-16 Aventis Pharma S.A. Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
JP2012522847A (ja) * 2009-04-06 2012-09-27 アジオス ファーマシューティカルズ， インコーポレイテッド ピルビン酸キナーゼｍ２調節剤、治療組成物および関連する使用方法
US8889667B2 (en) 2010-12-29 2014-11-18 Agios Pharmaceuticals, Inc Therapeutic compounds and compositions
US9115086B2 (en) 2009-06-29 2015-08-25 Agios Pharmaceuticals, Inc. Therapeutic compositions and related methods of use
US9181231B2 (en) 2011-05-03 2015-11-10 Agios Pharmaceuticals, Inc Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
US9221792B2 (en) 2010-12-17 2015-12-29 Agios Pharmaceuticals, Inc N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators
US9328077B2 (en) 2010-12-21 2016-05-03 Agios Pharmaceuticals, Inc Bicyclic PKM2 activators
US9365545B2 (en) 2013-03-15 2016-06-14 Agios Pharmaceuticals, Inc Therapeutic compounds and compositions
US9980961B2 (en) 2011-05-03 2018-05-29 Agios Pharmaceuticals, Inc. Pyruvate kinase activators for use in therapy
US10029987B2 (en) 2009-06-29 2018-07-24 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
US11234976B2 (en) 2015-06-11 2022-02-01 Agios Pharmaceuticals, Inc. Methods of using pyruvate kinase activators

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0784055A4 (en) * 1994-09-26 1998-01-07 Daiichi Seiyaku Co PYRIMIDINYLPYRAZOLE DERIVATIVE
US5852019A (en) * 1994-09-26 1998-12-22 Daiichi Pharmaceutical Co., Ltd. Pyrimidinylpyrazole derivatives
EP1022270A4 (en) * 1997-01-27 2002-01-30 Daiichi Seiyaku Co PIRAZOLE DERIVATIVES
US6552018B1 (en) 1997-01-27 2003-04-22 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives
FR2850379A1 (fr) * 2003-01-28 2004-07-30 Aventis Pharma Sa Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
WO2004078732A1 (fr) * 2003-01-28 2004-09-16 Aventis Pharma S.A. Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
JP2012522847A (ja) * 2009-04-06 2012-09-27 アジオス ファーマシューティカルズ， インコーポレイテッド ピルビン酸キナーゼｍ２調節剤、治療組成物および関連する使用方法
US9657004B2 (en) 2009-04-06 2017-05-23 Agios Pharmaceuticals, Inc Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use
US9938259B2 (en) 2009-04-06 2018-04-10 Agios Pharmaceuticals, Inc. Therapeutic compositions and related methods of use
US12428376B2 (en) 2009-06-29 2025-09-30 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
US9115086B2 (en) 2009-06-29 2015-08-25 Agios Pharmaceuticals, Inc. Therapeutic compositions and related methods of use
US11866411B2 (en) 2009-06-29 2024-01-09 Agios Pharmaceutical, Inc. Therapeutic compounds and compositions
USRE49582E1 (en) 2009-06-29 2023-07-18 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
US10029987B2 (en) 2009-06-29 2018-07-24 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
US10988448B2 (en) 2009-06-29 2021-04-27 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
US9221792B2 (en) 2010-12-17 2015-12-29 Agios Pharmaceuticals, Inc N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators
US9328077B2 (en) 2010-12-21 2016-05-03 Agios Pharmaceuticals, Inc Bicyclic PKM2 activators
US10087169B2 (en) 2010-12-21 2018-10-02 Agios Pharmaceuticals, Inc. Bicyclic PKM2 activators
US9199968B2 (en) 2010-12-29 2015-12-01 Agios Pharmaceuticals, Inc. Therapeutic compounds and compositions
US8889667B2 (en) 2010-12-29 2014-11-18 Agios Pharmaceuticals, Inc Therapeutic compounds and compositions
US9980961B2 (en) 2011-05-03 2018-05-29 Agios Pharmaceuticals, Inc. Pyruvate kinase activators for use in therapy
US10632114B2 (en) 2011-05-03 2020-04-28 Agios Pharmaceuticals, Inc. Pyruvate kinase activators for use in therapy
US11793806B2 (en) 2011-05-03 2023-10-24 Agios Pharmaceuticals, Inc. Pyruvate kinase activators for use in therapy
US9181231B2 (en) 2011-05-03 2015-11-10 Agios Pharmaceuticals, Inc Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
US12377093B2 (en) 2011-05-03 2025-08-05 Agios Pharmaceuticals, Inc. Pyruvate kinase activators for use in therapy
US9365545B2 (en) 2013-03-15 2016-06-14 Agios Pharmaceuticals, Inc Therapeutic compounds and compositions
US11234976B2 (en) 2015-06-11 2022-02-01 Agios Pharmaceuticals, Inc. Methods of using pyruvate kinase activators

Also Published As

Publication number Publication date
JPH0430924B2 (enExample) 1992-05-25

Similar Documents

Publication Publication Date Title
JPS61129129A (ja) 抗腫瘍剤
EP0774255A1 (en) Use of ursolic acid for the manufacture of a medicament for suppressing metastasis
JP5118863B2 (ja) 催眠用医薬組成物
JPH06500537A (ja) アテローム硬化症の治療のためのアリールヒドロキシ尿素化合物の使用
US4892876A (en) Method for inhibiting HIV and an pharmaceutical composition therefor
JPS63267781A (ja) 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
EP1203585B1 (en) Anti-ischemic agent
US3519712A (en) Therapeutic compositions comprising n-methylglucamine and coumermycin or salts thereof
US3906107A (en) Aminoalkyl sulfate esters with diuretic activity
JPS61129124A (ja) 抗腫瘍剤
JPS61129126A (ja) 抗腫瘍剤
JPS5938207B2 (ja) 腎疾患治療剤
JPS61134315A (ja) 解熱鎮痛剤
US6693100B1 (en) Pharmaceutical compositions for treating psoriasis
JPS6058726B2 (ja) プリン誘導体を有効成分として含有する抗アレルギ−，鎮痛，鎮静剤
JPS61129127A (ja) 抗腫瘍剤
JPH0616561A (ja) 抗レトロウイルス剤
JPH02178227A (ja) 腎炎治療剤
JPS61129121A (ja) 抗腫瘍剤
Barbour et al. The use of carbethoxysyringoyl methylreserpate in hypertension
JPS61130218A (ja) 抗腫瘍剤
EP1214073A2 (en) Use of dexrazoxane for treating psoriasis
CN121226302A (zh) 刺槐素与唑吡坦共晶物及制备方法和其组合物与用途
CN121226301A (zh) 刺槐素与哌嗪共晶物及制备方法和其组合物与用途
JPWO1989001778A1 (ja) 血小板減少予防及び治療剤